SCL-GPI is a member of the Health Equity Collaborative and supports our respective organization's efforts to reform the Federal Government's 340B Drug Pricing Program. The program was intended to help underserved patients access very low-priced drugs, but unethical PBMs and large hospitals have been taking those benefits to improve their profits. October 31, 2025
Letter from SCL-GPI to the ranking members of the Senate HELP Committee to show support for efforts to reform the 340B Drug Pricing Program, October 20, 2025